Journal of Clinical Oncology
Articles in this Issue
See Her Screen Her: An opportunistic VIA screening and HPV vaccination among female patient attendants at a tertiary cancer care center in a low-resource setting.
e22518 Background: Cervical cancer remains one of the major causes of cancer mortality in low- and middle-income countries...
Impact of baseline severe cytopenia on post–BCMA CAR T-cell therapy outcomes in multiple myeloma: A propensity-matched multicenter study.
e19527 Background: Severe cytopenias are common in relapsed/refractory multiple myeloma (MM) and may influence outcomes af...
Efficacy and safety of durvalumab with or without tremelimumab in metastatic NSCLC: A meta-analysis of randomized controlled trials.
e20568 Background: Lung cancer remains the leading cause of cancer-related mortality worldwide. Non–small cell lung cancer...
An immune-related pathologic response score as a predictor of survival after immune checkpoint inhibitor–based conversion therapy in hepatocellular carcinoma.
4162 Background: Immune checkpoint inhibitor (ICI) based conversion therapy is increasingly utilized in the management of...
Association of caregiver and patient burden with ALK-positive advanced non–small cell lung cancer in Germany, the United Kingdom, and the United States.
e20768 Background: Patients with advanced NSCLC (aNSCLC) can experience significant disease burden with respect to symptom...
A phase II study of ubenimex combined with pembrolizumab, nab-paclitaxel, and carboplatin for previously untreated advanced squamous non–small cell lung cancer: TORG2241(UBE-Q).
8559 Background: Pembrolizumab plus platinum-based chemotherapy is a standard first-line treatment for previously untreate...
Palliative care utilization in patients with <i>EGFR</i> -mutant metastatic non-small cell lung cancer receiving first-line <i>EGFR</i> TKIs.
e24076 Background: Patients with metastatic EGFR -mutant NSCLC experience prolonge...
Effect of "watch and wait" on fear of recurrence in rectal cancer: A multicenter cross-sectional study.
12116 Background: Total neoadjuvant therapy (TNT) is now the standard of care for locally advanced rectal cancer. Watch-an...
H&E 2.0: Artificial intelligence–driven prediction of N256-glycosylated CEACAM5/6 expression in esophageal and gastric adenocarcinomas.
4018 Background: The antibody-drug conjugate (ADC) EBC-129 has shown promising clinical responses in a Phase 1A/B trial, w...
NCORP Symptom Science Portfolio analysis (2014-2025).
e24054 Background: Symptom science research constitutes the largest share of the Division of Cancer Prevention’s portfolio...
Barriers and facilitators to teleoncology care delivery for cognitively impaired older cancer patients: Clinician perspectives.
e13710 Background: Telehealth has improved access to care and is increasingly used in oncology. However, its expansion has...
Respiratory malignancies among patients hospitalized with acute respiratory failure: Nationwide trends in complications, resource utilization, and outcomes.
e20085 Background: Acute respiratory failure (ARF) is a common cause of hospitalization among patients with lung cancer. P...
Variation in metastatic colorectal cancer (mCRC) patient survival among different oncology practice settings with guideline-concordant molecular testing.
e23082 Background: Molecular testing is paramount for treating patients (pts) with mCRC. Guidelines, including ASCO and NC...
Prognostic impact of comorbidity burden on overall survival in patients with Waldenström macroglobulinemia in the United States.
7083 Background: Waldenström macroglobulinemia (WM), also known as lymphoplasmacytic lymphoma (LPL), is a rare indolent No...
Primary results of the phase 3 peak study of bezuclastinib + sunitinib vs sunitinib monotherapy in advanced gastrointestinal stromal tumors (GIST).
11500 Background: GIST, the most common mesenchymal malignancy of the gastrointestinal tract, is commonly driven b...
Tumor methylation subtypes as a predictor of clinical outcome to immunotherapy in pleural mesothelioma patients from the NIBIT-EPI-MESO study.
8052 Background: Pleural mesothelioma (PM) is an aggressive malignancy with a poor prognosis. The clinicalefficacy of stan...
Clinical characteristics, treatment patterns, and outcomes of patients aged ≥ 80 years with aggressive lymphomas: A real-world single-center experience.
e13772 Background: Population aging has led to a growing number of patients aged ≥80 years diagnosed with lymphoma. Howeve...
Outcomes of immune checkpoint inhibitor therapy in patients with pre-existing autoimmune disease: A propensity-matched real-world analysis of baseline corticosteroid use.
e23096 Background: Patients with pre-existing autoimmune disease are frequently excluded from immune checkpoint inhibitor...
Budget impact analysis of heated intraperitoneal chemotherapy at interval cytoreductive surgery for stage III high grade serous carcinoma of tubo-ovarian origin.
5589 Background: Heated Intraperitoneal Chemotherapy (HIPEC) at interval cytoreductive surgery (ICS) for high grade serous...
Association of GLP-1 receptor agonist use with overall survival in patients with colorectal cancer and type 2 diabetes: A multicenter real-world study.
e15556 Background: Colorectal cancer (CRC) is closely linked to obesity and type 2 diabetes mellitus (T2DM), conditions as...
Pilot study of CTC enumeration and AR-V7 detection using a microporous chip filtration system in metastatic prostate cancer.
e17054 Background: Circulating tumor cells (CTC) are one of key components of liquid biopsy which provide phenotype and mo...
Effects of SECN-15, a neuropilin-1–targeting antisense oligonucleotide, on resistance to immune checkpoint inhibitors in preclinical tumor models.
2613 Background: Neuropilin-1 (NRP1) is a transmembrane co-receptor implicated in tumor growth, metastasis, angiogenesis,...
Comparative assessment of skin toxicity in prone vs supine positions during preoperative breast radiotherapy: A systematic review and meta-analysis.
e24148 Background: Skin toxicity remains one of the most common side effects of breast radiotherapy and can meaningfully a...
First-line carboplatin-paclitaxel (CP) for metastatic anal squamous cell carcinoma (ASCC): An analysis of dosing schedules.
e15501 Background: CP is the backbone of first-line therapy for recurrent or metastatic ASCC. In practice, Q3-week CP has...
Real-world cardiotoxicity with HER2 antibody–drug conjugates and survival after treatment continuation.
1057 Background: HER2 antibody–drug conjugates (ADCs) are central to HER2-positive breast cancer (BC) treatment, yet cardi...